Clinical Trial Update: Subjective Well Being of Schizophrenic Patients in Greece

View source ↗

Summary

AstraZeneca-sponsored clinical trial in Greece assessing subjective well-being in schizophrenia patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED